Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Snap, HCA Healthcare, Twitter And Some Other Big Stocks Moving Lower On Friday

Published 21/10/2022, 17:40
© Reuters.  Snap, HCA Healthcare, Twitter And Some Other Big Stocks Moving Lower On Friday
HCA
-
TWTR
-
TWTR34
-
H1CA34
-
HCA
-

U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Friday. Here are some big stocks recording losses in today’s session.

  • Tenet Healthcare Corporation (NYSE: NYSE:THC) shares tumbled 30.4% to $37.78 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
  • Snap Inc . (NYSE: NYSE:SNAP) fell 30.3% to $7.53 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
  • SVB Financial Group (NASDAQ: SIVB) dropped 20.5% to $240.49 after reporting Q3 earnings.
  • Surgery Partners, Inc. (NYSE: SGRY) declined 12.6% to $22.97.
  • Robert Half International Inc. (NYSE: NYSE:RHI) shares dropped 10.1% to $71.78 after reporting downbeat Q3 earnings.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 9.4% to $4.5766.
  • HCA (NYSE:HCA) Healthcare, Inc. (NYSE: HCA) dropped 9.2% to $189.50 after the company reported worse-than-expected Q3 sales results.
  • Select Medical Holdings Corporation (NYSE: SEM) declined 8.3% to $21.62.
  • Pinterest (NYSE:PINS), Inc. (NYSE: PINS) fell 7.1% to $21.35 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
  • Twitter, Inc. (NYSE: TWTR) shares fell 4.3% to $50.18. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.